Pfenex Inc Stock News

Midway through trading Wednesday, the Dow traded down 2.63% to 23319.37 while the NASDAQ fell 1.99% to 8346.64. The S&P also fell, dropping 2.73% to 2,768.24. The U.S. is the...

Movers Indices • S&P 500 ETF (NYSE:SPY) decreased 2.13% to $277.75. • Nasdaq ETF (NASDAQ:QQQ) decreased 1.57% to $208.53. • Dow Jones Industrial Average ETF (...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-Week Highs April 14) Bio-Rad Laboratories, Inc...

Pfenex Inc. (NYSE American: PFNX) announced today that the U.S. Food and Drug Administration (FDA), informed Alvogen Malta Operations Ltd., the Company’s commercialization partner for PF708, via a G

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Incyte (INCY), SAGE Therapeutics (SAGE) and Pfenex (PFNX)

Pune, April 08, 2020 -- The global osteoporosis treatment market size is projected to reach USD 15.08 billion by the end of 2026. The emphasis on early detection and treatment.

Eef Schimmelpennink became the CEO of Pfenex Inc. (NYSEMKT:PFNX) in 2017. This analysis aims first to contrast CEO...

Q4 2019 Pfenex Inc Earnings Call

Pfenex Inc. (NYSE American: PFNX) is a development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® to develop and improve protein therapies for unmet pati

NEW YORK, NY / ACCESSWIRE / March 11, 2020 / Pfenex Inc (NYSEAMERICAN:PFNX) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 11, 2020 at 4:30 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Aytu

Companies Reporting Before The Bell United Natural Foods, Inc. (NYSE: UNFI ) is estimated to report quarterly earnings at $0.27 per share on revenue of $6.14 billion. Express, Inc. (NYSE: EXPR ) is pr